|30th September 2020||Ronald B Sr Kalich||459||Grant/award etc.||$38.91||$17,859.69|
|30th September 2020||David Dantzker||417||Grant/award etc.||$38.91||$16,225.47|
|22nd September 2020||Joseph J. Stich||1,300||Bona fide gift||$0.00|
|1st September 2020||Gary R Maharaj||3,000||Open or private sale||$45.07||$135,206.40|
|19th August 2020||Joseph J. Stich||2,500||Open or private sale||$46.71||$116,780.75|
|7th August 2020||Lisa Wipperman Heine||1,200||Open or private sale||$18.03||$21,636.00|
|3rd August 2020||Gary R Maharaj||3,000||Open or private sale||$47.44||$142,333.80|
|22nd July 2020||Joseph J. Stich||9,418||Payment by withholding||$44.97||$423,527.46|
|22nd July 2020||Joseph J. Stich||12,612||Exercise of derivative||$22.58||$284,778.96|
|17th July 2020||Timothy J. Arens||95||Payment by withholding||$45.34||$4,307.30|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.
SurModics, Inc. engages in the provision of medical device and in vitro diagnostic technologies to the healthcare industry. It operates through Medical Device and In Vitro Diagnostics segments. The Medical Device segment designs, develops, and manufactures interventional medical devices, surface modification coating technologies, as well as drug-delivery coating technologies. The In Vitra Diagnostics segment consists of component products and technologies for diagnostic test kits and biomedical research applications.